Search results

Altasciences determines the suitability of nano milling for a client’s highly active compound with very poor aqueous solubility and less than desirable bioavailability.

A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Our engineers were able to diagnose and solve two problems.

In our February 3rd blog, we discussed the difference between genetics and genomics. Today, we focus on the advances being made in medicine that are affected or influenced by the increased understanding of the human genome.

Explore Canada's advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.

Learn more about how Altasciences can test cognition, and the impact of driving under the influence of medication, using our state-of-the-art driving simulators.